On February 25, 2026, Ionis Pharmaceuticals, Inc. announced its financial results for the quarter and fiscal year ended December 31, 2025, using both GAAP and non-GAAP measures. The non-GAAP results exclude non-cash compensation expenses related to equity awards to provide a clearer picture of the company's performance.